Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Accounts Payables (2020 - 2025)

Historic Accounts Payables for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $16.1 million.

  • Treace Medical Concepts' Accounts Payables fell 1365.22% to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year decrease of 1365.22%. This contributed to the annual value of $10.5 million for FY2024, which is 1109.42% down from last year.
  • As of Q3 2025, Treace Medical Concepts' Accounts Payables stood at $16.1 million, which was down 1365.22% from $20.0 million recorded in Q2 2025.
  • Over the past 5 years, Treace Medical Concepts' Accounts Payables peaked at $21.1 million during Q1 2024, and registered a low of $1.3 million during Q1 2021.
  • For the 5-year period, Treace Medical Concepts' Accounts Payables averaged around $9.7 million, with its median value being $8.7 million (2022).
  • In the last 5 years, Treace Medical Concepts' Accounts Payables skyrocketed by 31664.7% in 2024 and then crashed by 3747.69% in 2025.
  • Over the past 5 years, Treace Medical Concepts' Accounts Payables (Quarter) stood at $4.1 million in 2021, then surged by 113.71% to $8.7 million in 2022, then skyrocketed by 36.54% to $11.8 million in 2023, then decreased by 11.09% to $10.5 million in 2024, then surged by 53.04% to $16.1 million in 2025.
  • Its Accounts Payables was $16.1 million in Q3 2025, compared to $20.0 million in Q2 2025 and $13.2 million in Q1 2025.